Trade Summary

4 days ago, Wagenheim Philip, serving as Dir at Immunome Inc. (IMNM), sold 65,000 shares at $20.55 per share, for a total transaction value of $1,335,626.00. Following this transaction, Wagenheim Philip now holds 341,147 shares of IMNM.

This sale represents a 16.00% decrease in Wagenheim Philip's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, March 20, 2026 and publicly disclosed via SEC Form 4 filing on Monday, March 23, 2026, 3 days after the trade was made.

Immunome Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.